INTRODUCTION
Exercise-induced bronchoconstriction (EIB) is related to increased ventilation (VE) during exercise and describes the transient airway narrowing following exercise (Spooner, Saunders, & Rowe, 2002) . Usually, maximum bronchoconstriction occurs 3-15 minutes after exercise (Brudno, Wagner, & Rupp, 1994) and subsides spontaneously within 20-60 minutes (Rupp, 1996) . The symptoms of EIB may include coughing, wheezing, shortness of breath, premature fatigue, and chest tightness (Spooner et al., 2002; Spooner, Spooner, & Rowe, 2003) . As EIB often is the first sign of asthma (Ernst, Ghezzo, & Becklake, 2002) a reliable diagnosis and optimal treatment are important for affected people's physical performances and self-esteem.
PREVALENCE OF EXERCISE-INDUCED BRONCHOCONSTRICTION
EIB is reported in most asthmatic patients, and is also more frequent in atopic (allergic) individuals (Rupp, 1996) . However, EIB can also occur in individuals without signs of clinical asthma or atopy, such as elite athletes (Rundell & Slee, 2008) . The true prevalence of EIB in the general population is poorly defined (Rupp, 1996) , and the reported prevalence in the literature varies due to discrepancy in methods used for diagnosis, e.g. self-reported symptoms versus objective lung-function measurements (Rundell et al., 2001) . Nevertheless, Rupp (1996) reported the prevalence of EIB in the general population to be 12-15% and other studies suggest a prevalence rate between 26% and 50% among specific athletes (Mannix, Farber, Palange, Galassetti, & Manfredi, 1996; Rundell et al., 2001; Wilber et al., 2000) . EIB may be most frequent in children and young adults (McFadden & Gilbert, 1994) and it is reported more prevalent in female Olympic winter sport athletes than their male counterparts (Wilber et al., 2000) . However, in the absence of valid studies the true prevalence is uncertain.
EXERCISE CHALLENGE TEST
Symptoms alone are not sensitive nor specific predictors of EIB (Rundell et al., 2001) . In order to diagnose the presence of EIB, reported symptoms can be evaluated using different provocation tests. A standardized exercise challenge test (ECT) on a treadmill is commonly performed, whereby a possible impairment of pulmonary function is measured by spirometry.
The response to exercise is assessed as the post-exercise reduction in forced expiratory volume in one second (FEV 1 ) expressed as a percentage of the pre-exercise value. The
European Respiratory Society (ERS) and American Thoracic Society (ATS) recommendations both set a 10% reduction in FEV 1 as a criterion for EIB (Crapo et al., 2000; Sterk et al., 1993) .
Intensity of the exercise challenge test
Exercise intensity influences the sensitivity of an ECT because a major factor determining the severity of EIB is the pulmonary VE reached and sustained during exercise. An ECT can be sensitive and specific if exercise minute ventilation is standardized (Weiler et al., 2007) .
Therefore, ATS guidelines state that VE during an ECT should reach 40-60% of the predicted maximum voluntary ventilation (MVV), estimated as FEV 1 ×35, for a period of 4 minutes with total test duration of 6-8 minutes. Correspondingly, the guidelines recommend an exercise intensity of 80-90% of heart rate maximum (HR max ), estimated by the formula:
HR max = 220 − age, for a period of 4 minutes (Crapo et al., 2000) . However, as there is high individual variance in HR max (Tanaka, Monahan, & Seals, 2001 ) it has been reported that heart rate based ATS standard protocols may not ensure sufficient exercise intensity to induce bronchoconstriction (Trümper, Mäueler, Vobejda, & Zimmermann, 2009 ). Moreover, a study by Carlsen, et al. (2000) has demonstrated a significant increased reduction in lung function after an ECT performed at 95% of estimated HR max compared to an intensity of 85% of estimated HR max . Thus, adequate intensity of an ECT may be essential to achieve a reliable diagnosis of EIB.
Repeated exercise challenge test
The impact of a repeated ECT in a clinical setting is not well established. However, the reproducibility of an ECT has been investigated. Dahlén et al. (2001) demonstrated the reproducibility of maximum per cent reduction in FEV 1 as an outcome measurement after a standardized ECT to be 72%, hence the inter-subject variability accounted for 28% of the total variance. Furthermore, a recent study identified agreement of 76% in test results between two ECTs when examining subjects without a definite diagnosis of asthma. The results demonstrated variability in the presence and severity of EIB, despite standardization of intensity, duration, and condition of the inspired air, and also suggest that more than one ECT may be required to exclude or diagnose EIB (Anderson et al., 2010) .
The HR formula recommended by the ATS is usually applied (Carlsen et al., 2008 ). Trümper et al. (2009 suggested in the previously mentioned study that individual HR max should be achieved before conducting an ECT in order to ensure adequate intensity of the test. In addition, a potential learning effect from foregoing practise tests has been reported in e.g.
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COPD (chronic obstructive pulmonary disease) patients (ATS, 2003; Salzman, 2009; Swinburn, Wakefield, & Jones, 1985) . Therefore, conducting a repeated ECT, based on the knowledge of the first test, introduces the possibility to adjust the exercise protocol on an individual basis and may also result in the subject tested becoming accustomed to the testing procedure. Thus, we hypothesized greater intensities of the repeated ECTs, and consequently a greater number of positive repeated ECT results. Also, because of the reported variability in repeated ECT results, an additional test may be useful. To our knowledge, no prior studies have examined the impact of a repeated ECT in which the exercise protocol can be adjusted.
Thus, in our opinion the usefulness of performing a repeated ECT, as opposed to one test to achieve more reliable results in general, needs to be more extensively investigated.
The aim of the study was to evaluate whether a repeated ECT requires reconsideration of the final EIB diagnosis due to a difference in test results, and if so, whether the difference is associated with exercise intensity.
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MATERIAL AND METHODS

STUDY DESIGN
We conducted a test-retest evaluation study in a clinical setting. The evaluation was designed to compare the number of positive ECTs versus negative ECTs performed on two different occasions, and to assess a possible association between the test results and exercise intensity.
Recruitment and testing took place at the Clinic for Allergies and Airway Diseases (Klinikk for allergi og luftveissykdommer, KAL) in Oslo.
SUBJECTS
Two pulmonologists recruited males and females during consultations following routine testing at KAL. The subjects, all of whom were volunteers, were enrolled if they were aged between 16 years and 45 years and had been referred to KAL by their general practitioners. At least three out of five questions relating to symptoms strongly suggesting EIB (coughing, wheezing, shortness of breath, lack of physical performance, and chest tightness) had to be confirmed by the subject in order for them to be included in the study (Appendix 1: Inclusion form). This was to increase the positive predictive value of the ECTs. Subjects who had formerly been diagnosed with and treated for asthma and who still fulfilled the inclusion criteria were also included in the study. Written informed consent was obtained from each subject (Appendix 2: Informed consent).
Exclusion criteria were evaluated by the responsible pulmonologist and involved the lack of ability to perform an ECT with maximum effort, clearly abnormal electrocardiography (ECG), uncontrolled hypertension, or any known pulmonary diseases other than asthma.
A total of 20 subjects, 12 females and 8 males, between 18 and 39 years of age were included.
All subjects were Norwegian with the exception of one who was African. Three subjects participated in competitive sports. Eleven subjects undertook regular physical activity in their leisure time, and six subjects rarely or never undertook physical activity. Three subjects had not used a treadmill before. One subject had performed an ECT at the age of 8 years, and two subjects had completed a laboratory assignment which involved performing an ECT. Ten subjects used asthma medication, ten subjects did not use any asthma medication and two subjects used antihistamines.
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CONDITIONS BEFORE TESTS
All subjects reported feeling well on the days when the tests were performed and also in the three preceding days (no sick leave from school or work). Subjects with an ongoing respiratory tract infection or recent respiratory infection evaluated by the responsible pulmonologist had their designated day of testing postponed. No exercise was undertaken (prior to the ECT) on the days of testing. This was because of the possibility of developing refractoriness, whereby repeated exercise under identical conditions induces less than 50% of the initial asthmatic response (Lee & Anderson, 1985) . Anti-asthmatic medication and antihistamines were withheld in accordance with ERS guidelines (Roca et al., 1997 The procedure on test day 1 included resting blood pressure measurement, resting ECG recording, MVV measurements, an ECT, and treatment (Salbutamol).
Test day 2:
The procedure on test day 2 was identical to that on test day 1, except for the exclusion of resting blood pressure measurement and resting ECG recording. In addition, the exercise protocol of ECT 2 was adjusted by the test technician in collaboration with the test subject, based on ECT 1. If the subject ran for less than 8 minutes in ECT 1, an increased running time was encouraged in ECT 2. If subject was not completely exhausted after 8 minutes in ECT 1, speed and/or elevation of ECT 2 was increased if feasible. If the subject reported that the mask was the reason for terminating ECT 1, he or she was informed of the possibility of taking it off and continuing to run rather than terminating ECT 2. If the subject reported stiff legs as the reason for terminating ECT 1, speed and/or elevation of ECT 2 was adjusted.
OUTCOMES
The primary outcomes were maximum reduction in FEV 1 from before to after ECT 1 and ECT 2 (% pre-exercise), and exercise intensity measurements (VE and HR) in ECT 1 and ECT 2. In addition, oxygen uptake (VO 2 ), breathing frequency (BF), respiratory exchange ratio (RER), and breathing reserve (BR) were measured.
MEASUREMENTS Anthropometric data
Anthropometric data (age, sex, height, and weight) were recorded as a basis for determining individual predicted values and to express oxygen uptake related to bodyweight. Height (to the nearest centimetre) and weight (to the nearest kilogram) were measured while the test subjects were clothed, but without shoes.
Skin prick test
Skin prick tests were performed in accordance with published guidelines (Dreborg, 2005) with the following allergens: horse dander, dog dander, cat dander, rabbit dander, birch pollen, grass pollen (Timothy), mug worth pollen, Alternia tenuis, Cladosporium herbarum, house dust mites (Dermatophagoides pteronyssinus), and latex (Soluprick, ALK, Copenhagen, Denmark and Allergopharma, Hamburg, Germany).
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The criterion for being considered allergic to an allergen was a wheal size > 3 mm (Sporik, Hendersom, & Hourihane, 2009 
Lung function with reversibility
Lung function with reversibility was measured by a spirometer (Flowhandy ZAN 100 USB, nSpire Health GmbH, Oberthulba, Germany) according to published guidelines (Miller et al., 2005) . FEV 1 in litres and in % of predicted and the ratio FEV 1 /FVC (forced vital capacity) are
given. Reversibility was assessed following inhalation of Salbutamol (0.4 mg from a pressurized metered dose inhaler). An increase in FEV 1 of ≥ 12% and ≥ 200 ml above baseline was taken as a positive response to Salbutamol. We used accepted reference values and ethnicity was taken into account, i.e. a correction factor was applied to adjust European reference values for application to Africans .
Static lung volumes
Static lung volumes were measured using bodyplethysmography (ZAN 500 Body USB, nSpire Health GmbH, Oberthulba, Germany), according to published guidelines (Wanger et al., 2005) . Among the subdivisions of static lung volumes, RV and TLC were recorded. We used accepted reference values as mentioned above .
Pulmonary diffusing capacity for carbon monoxide
DL,CO was measured using a CO/CH 4 (methane) analyser (ZAN 300 MGA USB, nSpire Health GmbH, Oberthulba, Germany), according to published guidelines (Cotes, Chinn, Quanjer, Roca, & Yernault, 1993) . We used accepted reference values as mentioned above .
Blood pressure
For safety reasons, resting blood pressure was measured prior to exercise by the use of an automated blood pressure device (M3 Intellisense HEM-7051-E, OMRON HEALTHCARE, Kyoto, Japan). We measured blood pressure once.
Electrocardiography
Resting 12-lead ECG was measured for safety reasons prior to exercise by the use of an ECG recorder (AR 1200 ADV, Cardiette, Cavareno, Italy). Prior to the ECT, interpretation of the electrocardiogram was performed by the pulmonologist responsible.
Lung function before and after exercise
Lung function was measured using a spirometer (Flowhandy ZAN 100 USB, nSpire Health GmbH, Oberthulba, Germany) according to published guidelines (Miller et al., 2005) . FEV 1 and FVC were measured before and 1, 3, 6, 10, and 15 minutes after exercise and 10 minutes after inhalation of Salbutamol (0.4 mg). Full FVC manoeuvres were not requested after exercise because this might have tired the subjects (Weiler et al., 2007) . Salbutamol was included to reverse possible bronchoconstriction. We used accepted reference values, as mentioned above .
Maximum voluntary ventilation
Before exercise, MVV was measured using an analyser (ZAN 600 USB, nSpire Health GmbH, Oberthulba, Germany) according to published guidelines (Miller et al., 2005) . The value was multiplied by six which results in the MVV expressed in litres per minute (L min -1 ).
This was measured to calculate BR after measuring VE peak during the ECT (MVV − VE peak = BR) and to calculate ventilation in percentage of MVV (VE % MVV) for the last 4 minutes of the ECTs.
Exercise challenge test
The ECTs were performed under laboratory conditions according to ERS guidelines (Roca et al., 1997) . ECT 1; the temperature was between 18°C and 21°C, the relative humidity was between 20% and 46%, and the barometric pressure was between 97.7 kPa and 101.4 kPa.
ECT 2; the temperature was between 19°C and 22°C, the relative humidity was between 19%
and 45%, and the barometric pressure was between 96.1 kPa and 102.0 kPa. The mean outdoor temperature in Oslo 30 minutes before scheduled testing at KAL was −2 (SD 6) °C and −4 (SD 4) °C on test day one and two respectively.
Exercise was performed by running on a motorized treadmill (h/p/cosmos quasar med 4.0, h/p/cosmos sports & medical gmbh, Nussdorf-Traunstein, Germany) for 6−8 minutes. The initial incline of the treadmill was 3%. The speed and incline were adjusted throughout the test with the aim of achieving a workload of ≥ 95% of estimated HR max (220 − age) in the last 20 4 minutes of each test. Each subject's VE and HR were monitored according to ATS and ERS guidelines, for both ECTs. The ventilation was > 40% of measured MVV and estimated MVV (FEV 1 ×35) for each subject, during each of the last 4 minutes of the tests. Also, the HR was >80% of estimated HR max for each subject during each of the last four minutes of the tests. In addition, the subjects assessed their own perception of effort and exhaustion immediately after completing the test by using the Borg CR 10 Scale for rating perceived exertion (Borg, 1998) . The test could have been stopped at any time. Furthermore, the subjects were wearing a chest belt and a harness, attached by rope to the crossbar of the treadmill's safety arch, and one pull on the rope would have activated the emergency stop.
VE, VO 2 , BF, and RER were measured during exercise. Each subject wore a face mask attached to a flow sensor (ZAN VIP flow sensor, nSpire Health GmbH, Oberthulba, Germany) which was connected to an analyser (ZAN 600 USB, nSpire Health GmbH, Oberthulba, Germany). In order to determine the respiratory flow, gas concentrations were and >40% was considered mild, moderate and severe respectively (Eggleston, 1984) . The highest recorded VE, HR, VO 2, BF, and RER values during exercise were determined as VE peak , HR peak, VO 2 peak , BF peak and RER peak . VO 2 and VE were both measured in L min -1 , BR in breath min -1 and HR in beats min -1 . ZAN-Tech Software was used to interpret the results.
STATISTICAL ANALYSIS
Subject characteristics are given individually and as mean values and standard deviations. The results are given as means with 95% confidence intervals. Paired t-tests were applied to assess differences in lung function between baseline and ECT 1 and between baseline and ECT 2.
They were also used to assess differences in intensity and maximum reduction in FEV 1 between ECT 1 and ECT 2. P-values of < 0.05 were considered statistically significant. All statistical analyses were performed using PASW V.18.0 for Windows software (SPSS Inc, Chicago, Illinois, USA). To create the graph, we used the SAS 9.2 statistical package (SAS Institute Inc., Cary, North Carolina, USA).
ETHICS
The study was performed in accordance with the principles stated in the Declaration of Study participation was evaluated to involve minimal health risk and the measurements were taken in concordance with regular clinical practice. To ensure subjects' safety, a medically responsible pulmonologist was available at all times during the testing, and a defibrillator was accessible in the laboratory exercise room. ECG registration and blood pressure measurement were included prior to the first ECT to increase safety level of maximal effort exercise tests.
Safety garments ensured that subjects could not fall off the treadmill, thus preventing any risk of injury. Table 1 shows a summary of the subjects' characteristics at baseline. Blood pressure, ECG, static lung volumes, and diffusing capacities were normal for all subjects. There were no significant differences in the group's lung function (FEV 1 and FVC) between baseline and test day 1 or between baseline and test day 2 (data not shown). 
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RESULTS
BASELINE CHARACTERISTICS
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COMPLIANCE AND ADVERSE EVENTS
The compliance with both ECTs was 100%. Dizziness and nausea were reported by several subjects, but with spontaneous recovery. On test day 1, irregular HR was recorded in three subjects and one subject did not measure VO 2 and RER due to equipment error. Also, one subject had a small face mask leakage, and one subject did not perform MVV due to having a headache. On test day 2, irregular HR was recorded in one subject. Also, two subjects were unable to complete the ECT wearing a face mask, due to the subjective feeling of not being able to breathe.
EXERCISE INTENSITY
On an individual base, exercise intensity measurements were similar for both tests. Also, the subjects' perceptions of their own efforts and level of exertion were similar in ECT 1 and ECT 2, and they reported ≥ 9 on Borg CR 10 Scale on both tests. Moreover, when assessed at group level, there were no significant differences in exercise intensity measurements (Table   2 ). Mean VE % MVV during the last 4 minutes of ECT 1 was 82% while for ECT 2 it was 81%. Mean VE % estimated MVV was 79% on ECT 1 and 81% on ECT 2. Mean HR % predicted HR max during the last four minutes was 94% on ECT 1 and 93% on ECT 2. Further, there were no significant differences in mean values of VE peak , HR peak , VO 2peak , BF peak , RER peak or BR between the two ECTs. The durations of the tests were also similar. The mean duration of ECT 1 was 6 minutes 52 seconds and the mean duration of ECT 2 was 6 minutes 49 seconds. Ventilation (VE) % of maximal voluntary ventilation (MVV); VE % of estimated MVV and heart rate (HR) % of estimated HR maximum (HR max ) in the last 4 minutes (mean) of exercise challenge test (ECT) 1 and 2; Peak ventilation (VE peak ), peak heart rate (HR peak ), peak oxygen uptake (VO 2 peak ), peak breathing frequency (BF peak ), peak respiratory exchange ratio (RER peak ) and breathing reserve (BR) of the ECTs. Difference: negative values relate to greater intensity of ECT1. Mean ECT2 − mean ECT 1 ≠ mean difference due to missing values.
REPEATED EXERCISE CHALLENGE TEST
The agreement in ECT results was 75% with 50% (10) negative and 25% (5) positive on both tests (Table 3) . Five subjects had a positive test result on only one of the two tests, three on the first test, and two on the second test. Disregarding test results, the maximum reduction in FEV 1 both increased and decreased from test 1 to test 2. 
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When assessed at group level, there was no significant difference in mean maximum reduction in FEV 1 (% pre-exercise) between ECT 1 and ECT 2. The mean maximum reduction in FEV 1 was 12% and 11% after ECT 1 and ECT 2 respectively. The mean difference was 1 percentage point (−2.5, 4.0), (p = 0.63), (N = 20). Furthermore, the mean reduction in FEV 1 after 1, 3, 6, 10, and 15 minutes after exercise and 10 minutes after medication was not significantly different between ECT 1 and ECT 2 (Fig. 1 ). 
DISCUSSION
There were no significant differences in the exercise intensity between the two tests.
However, five out of twenty subjects had different diagnostic test results. Hence, the differences in test results may not be related to the exercise intensity and it follows that accustomization to the testing procedure of the repeated ECT was not demonstrated.
In contrast to our hypothesis, the subjects seemed to achieve maximal performance already in the first ECT. Mean VE % measured and estimated MVV and mean HR % estimated HR max in the last 4 minutes of the tests were higher than minimum recommendation levels in both tests. Furthermore, mean heart rate in % of estimated HR max in the last 4 minutes of the tests was 94% and 93% in ECT 1 and ECT 2 respectively. This is close to 95%, which according to the study by Carlsen et al. (2000) may represent an adequate intensity level. The other intensity measurements (table 2) and the subjects' perception of their own exertion may also indicate maximal exertion. Consequently we believe that adjustments to the repeated exercise protocols were not able to result in any significant intensity enhancements.
Because we did not demonstrate any significant intensity differences, we were not surprised that we did not find a greater number of positive repeated test results. In fact, no trend was demonstrated in the five subjects with different test results: three subjects tested positive in the first test only, and two subjects tested positive on the second test only. Also, disregarding test results, the maximum reduction in FEV 1 both increased and decreased from test 1 to test 2
and thus did not demonstrate a trend either. Furthermore, the five subjects with different test results had only mild (10-20%) reductions in FEV 1 . This finding is in line with Anderson et al. (2010) , who suggest that for some subjects with mild symptoms more than one test may be required. They could neither explain the variation in their test results by a difference in exercise intensity (standardized), and hypothesized that the variability could have been due to environmental or dietary factors or to the intrinsic reproducibility of the test itself. between test 1 and 2. We can only speculate why, but the subject experienced coughing fits on both days which may have influenced the lung function measurements. A total of 10 subjects tested negative in both tests. Only subjects 15 and 19 had borderline results.
However, subject 15 demonstrated technical improvements during lung function measurements on test day 2.
Subjects 1, 7, and 10 tested positive in the first ECT only. In the case of subject 1, the reduction in FEV 1 from before to after exercise was only ≥ 10% after 15 minutes. Reduction in FEV 1 is usually sustained over two time points. Because we did not measure FEV 1 beyond 15 minutes we do not know whether the reduction in FEV 1 was sustained or could have been due to respiratory muscle fatigue (Rundell & Sue-Chu, 2010) . Also, occasional late phase responses may have been left out (Spooner et al., 2003) . Nevertheless, we did not operate with the criteria of sustained reduction over two time points to identify a positive test because one time point has been common practice (Roca et al., 1997) . Subject 7 on the other hand measured a reduction in FEV 1 from before exercise to 3, 6, and 10 minutes after exercise, but spontaneously recovered after 15 minutes. As maximum bronchoconstriction usually occurs 3-15 minutes after exercise, the spontaneous recovery after 15 minutes is ambiguous.
Subjects 12 and 18 tested positive in the second ECT only. In both tests both subjects felt discomfort while running with a face mask on. Subject 18 took the mask off during ECT 2, and ended up running for additional 2 minutes 45 seconds, which may have resulted in the sustained high ventilation required to elicit the EIB response.
Subjects 1, 10, 12, and 18 had borderline results in both tests. We used a cut-off value of 10% reduction in FEV 1 as criterion of a positive ECT. Interestingly, using a 15% cut-off value which also has been recommended (Eggleston, 1984; Haby, Peat, Mellis, Anderson, & Woolcock, 1995) left us with only one subject (7) with different test results.
Elevated FE NO has been reported in subjects with asthma (Kharnitonov et al., 1994) . In our study, baseline FE NO > 30 ppb was measured in four out of the five subjects who had two positive tests and in three out of the five subjects who had different test results. In addition, none of the subjects with two negative tests had FE NO > 30 ppb (two missing values) at baseline. Thus, the FE NO measurements might indicate a relation to the test results, which is interesting because baseline FE NO has been suggested to predict airway obstruction following exercise (García-Río et al., 2006) .
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Ten subjects used asthma medication, but still complained of EIB symptoms. Four tested positive in both tests, three tested negative in both tests, and three had different test results.
Further, five of the ten subjects used inhaled steroids. Two of these had two positive tests results, while the other three had two negative test results. It cannot be ruled out that the use of inhaled steroids decreased the likelihood of a positive test result in these subjects. (Crapo et al., 2000) .
The included subjects reported at least three EIB symptoms, yet 10 subjects tested negative in both ECTs. This finding is in line with those made by Rundell et al. (2001) , who concluded that self-reported EIB symptoms may yield both false positive and false negative test results.
Their study involved elite athletes, but their findings seem to agree with ours. Partly, the prevalence reported in the literature is based on self-reported symptoms (Voy, 1986; Weiler, Metzger, Donnely, Crowley, & Sharath, 1986) . Further, reported prevalence may also be based on ECTs. However, lack of standardization and especially inadequate intensity may reduce the sensitivity of exercise challenge tests (Carlsen et al., 2000) . Consequently, objective testing and standardized ECTs with adequate intensity are of importance both for diagnostic purposes, but also with regards to epidemiological studies.
We included subjects covering a large age range, thus reflecting a physically active period of life. The subjects turned out to be somewhat physically active in their leisure time, but only three subjects participated in competitive sports. The subjects' activity levels differed and this was reflected in their VO 2 measurements (range 32-61, mean 45) ml kg -1 min -1 . Moreover, three subjects had some previous ECT experience, in contrast to three subjects who had never run on a treadmill before. Regardless, this was not reflected in the subjects' ECT performances. Further, we included one African subject. Africans may have smaller lungs
with lower values for, for example, FEV 1 compared to Europeans .
However, ethnicity differences do not interfere with our primary outcomes.
The testing lasted from September to March and the number of days between ECT 1 and ECT 2 differed between 7 days and 28 days. We avoided the pollen season, but we cannot exclude that variation in outdoor weather conditions may have influenced the test results. However, the mean difference in temperature between the two tests was only 2°C. Also, the ECTs were not performed on the same time of day which may have influenced the results as well (Vianna et al., 2002) .
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The same test technician gave thorough information about study participation, reminded the subjects on each test day, guided the subjects through all measurements on test day 1 and test day 2, and encouraged maximal effort on the treadmill. We believe this was strength of our study, as there was 100% compliance in the case of both ECTs, despite the fact that performing an ECT is mentally and physically demanding. Also, the study was conducted in a centre of expertise and involved specialists in pulmonary diseases. We wanted to conduct a study that reflected the challenges in an everyday clinical setting. Conversely, the study could not be repeated as a blind study and also psychological factors influencing the test technician (researcher) and the subjects tested cannot be excluded.
Limitation of time made it unfeasible to achieve a sample size that would generate sufficient statistical power. Therefore, the results should be interpreted with care and the findings should not be generalized. However, the small sample size made it possible for us to study the participants individually.
Knowledge about the usefulness of a repeated ECT may be of importance to patients, clinical practice, and research work. A reliable assessment of EIB is of great value as optimal choice of treatment can be enabled and adaptations relating to exercise and sports can be made. Also, for a drug to be regarded as beneficial, knowledge about variability in maximum reduction in FEV 1 is crucial. Nevertheless, a repeated ECT may identify extra subjects with EIB who tested false negative the first time, as well as over diagnosing subjects with EIB the second time. A repeated ECT may require reconsideration of the final EIB diagnosis. However, different test results make the diagnostic decision difficult. Which test should be emphasized?
In any case, our results may suggest that a repeated ECT does not improve ECT performance with regard to exercise intensity.
In summary, our study showed a 25% divergence in the diagnostic results of two consecutive ECTs on subjects with symptoms strongly suggesting EIB. The difference in test results was not explained by a difference in exercise intensity. One objective of further research should be to develop a more precise exercise challenge test protocol with definite control parameters to provide a more reliable test.
Forespørsel om deltakelse i forskningsprosjektet:
"Sammenligning av to tredemølletester (provokasjonstester) for vurdering av anstrengelsesutløst astma".
Bakgrunn og hensikt:
Vi henvender oss til deg for å be om ditt samtykke til deltakelse i dette forskningsprosjektet. Formålet med studien er å få økt kunnskap knyttet til diagnostisering av anstrengelsesutløst astma. Studien gjennomføres som et samarbeidsprosjekt mellom "Klinikk for allergi og luftveissykdommer" (KAL), Oslo, og "Norges teknisk-naturvitenskapelige universitet", (NTNU), Trondheim. Denne forespørselen går til personer av begge kjønn i alderen 16 til 45 år som er henvist til KAL og hvor det er mistanke om anstrengelsesutløst astma.
Prosjektets innhold:
For deg innebaerer prosjektet at du kommer til klinikken (KAL) to adskilte testdager innenfor en 4 ukers periode i tidsrommet september 2010 -mai 2011. På hver testdag utføres en tredemølletest (provokasjonstest for anstrengelsesutløst astma). Lungefunksjon måles før og etter testen. Løp på tredemølle vil foregå i 6-8 minutter hvor du skal bli maksimalt sliten. Underveis registreres oksygenopptak og puls. Testen kan gi astmasymptomer som for eksempel tetthet i brystet, tungpustethet, hoste og økt slimproduksjon. Alle vil derfor få en inhalasjon med astmamedisin etter testen som en del av undersøkelsen.
Den første testdagen vil du bli bedt om å svare på et spørreskjema angående astma og luftveisplager. Det vil også bli målt blodtrykk og hjertets elektriske aktivitet vil bli registrert (hvile EKG).
Ved begge testdagene vil det i tillegg til tredemøllestesten bli utført andre lungefunksjonsmålinger som foretas rutinemessig hos alle pasienter som er henvist for astma og/eller pustebesvaer under anstrengelse: Maksimal frivillig ventilasjon måles for å beregne pustereserve etter at man har målt ventilasjon under tredemølletesten. Nivå av nitrogenoksid i utåndingsluft kan si noe om betennelsestilstanden i luftveiene på måletidspunktet. Lungevolum, luftveismotstand og diffusjonskapasitet benyttes som hjelpemiddel i diagnostisering og behandling av lungesykdom. 
APPENDIX 2: Informed consent
Hvorfor vi gjør denne studien: En tredemølletest blir vanligvis utført med en intensitet som er beregnet ut i fra estimert maksimal hjertefrekvens. Det har blitt hevdet at intensiteten som oppnås ved en slik tilnaerming ikke nødvendigvis er tilstrekkelig for å utløse sammentrekning av luftrørene (bronkiene). En repetert test, basert på kunnskap fra den første testen, kan gjøre det mulig å justere intensiteten mer individuelt. I tillegg har vi en hypotese, basert på klinisk erfaring, om at pasienter som gjennomfører en tredemølletest for andre gang utfører testen med en høyere intensitet da de er mer vant til testen og tredemølla. Hovedhensikten med prosjektet er å undersøke effekten av å gjennomføre en repetert tredemølletest for å diagnostisere anstrengelsesutløst astma. Ny kunnskap kan bidra til å tilby pasienter mer presise prosedyrer for å diagnostisere anstrengelsesutløst astma.
Mulige fordeler og ulemper:
Som deltaker har du mulighet til å bidra til ny og etterspurt kunnskap om diagnostisering av anstrengelsesutløst astma. Deltagelse i prosjektet medfører en grundig undersøkelse av lungefunksjon og ømfintlighet i luftveiene, som videre vil kunne benyttes som grunnlag for medisinsk behandling, og for å søke om tillatelse fra det internasjonale dopingbyrået, World Antidoping Agency (WADA) om å benytte astmamedisiner i forbindelse med idrett, dersom dette er aktuelt. For deltakere i prosjektet dekker klinikken (KAL) utgiftene ved de to testdagene, med unntak av reiseutgifter. Dersom du ikke ønsker å delta i studien, vil tester bli utført på vanlig måte. Under begge testdagene stilles strenge krav i forhold til deltakeres sikkerhet og studien er dekket av Norsk pasientskadeerstatning. Tredemølletesten kan gi astmasymptomer og kan oppfattes som ubehagelig. Behandling for eventuelt pustebesvaer under eller etter tredemølletesten vil kunne gis umiddelbart. De øvrige testene medfører svaert liten eller ingen risiko.
Hva skjer med testene og informasjonen om deg:
Dine resultater fra undersøkelsene formidles direkte til deg under legekonsultasjonen. I tillegg samles resultatene i flere forskningsrapporter. Alle opplysningene og testene vil bli behandlet uten navn og fødselsnummer eller andre direkte gjenkjennende opplysninger. En kode knytter deg til dine opplysninger og prøver, gjennom en navneliste. Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og som kan finne tilbake til deg. Det vil ikke vaere mulig å identifisere deg i resultatene av studien når disse publiseres.
Personvern og frivillig deltakelse:
Det er frivillig å delta i studien og du kan når som helst og uten å oppgi grunn trekke ditt samtykke. Dette vil ikke få konsekvenser for din videre behandling, eller forholdet til klinikken (KAL). Dersom du trekker deg fra studien har du rett til innsyn i data registrert om deg. Du kan kreve å få slettet innsamlede prøver og opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i vitenskapelige publikasjoner. Dersom du ønsker å delta, undertegner du samtykkeerklaeringen på siste side. Har du spørsmål kan du kontakte ansvarlig lege Thor Arne Grønnerød. Personopplysninger og data vil bli oppbevart til utgangen av 2021 og deretter slettet. S Sa am mt ty yk kk ke e t ti il l d de el lt ta ak ke el ls se e i i f fo or rs sk kn ni in ng gs sp pr ro os sj je ek kt te et t
